Literature DB >> 19649647

The inability of fully grown germinal vesicle stage oocyte cytoplasm to transcriptionally silence transferred transcribing nuclei.

Helena Fulka1, Zora Novakova, Tibor Mosko, Josef Fulka.   

Abstract

For somatic cell nuclear transfer cytoplasts from metaphase II, oocytes are exclusively used. However, it is evident that certain reprogramming activities are present in oocytes even at earlier stages of maturation. These activities are, however, only poorly characterised. The main reason for this is that even the intrinsic oocyte processes are insufficiently understood. The mammalian oocyte is a highly specialised cell that harbours many specific characteristics. One of these is its particularly large size when compared to somatic cells. As the oocyte enters the growth phase its volume, as well as the amount of material, increases considerably. Thus, it is clear that the oocyte must possess the machinery to accomplish this incredible material accumulation. When the growth phase is completed, the transcription ceases and the oocyte becomes transcriptionally inactive. In our study, we have used the model system of oocyte fusion (transcribing x non-transcribing germinal vesicle (GV) stage oocytes) as a substitute for a somatic cell nuclear transfer schemes where the somatic cell nucleus would be introduced into a cytoplast obtained from a GV stage oocyte. We wanted to determine if the fully grown GV stage oocyte could induce reprogramming of transcriptionally active transferred nucleus by suppressing this activity. In order to evaluate possible changes in transcriptional properties after nuclear transfer, we also investigated the mechanism of transcriptional silencing taking place when the oocyte reaches its full size as well as the fate of the components namely of the RNA polymerase II (Pol II) transcriptional and splicing machinery. Here, we show that while the Pol II is degraded in fully grown GV stage oocytes and the splicing proteins undergo significant rearrangement, these oocytes are unable to induce similar changes in transcriptionally active nuclei even after a prolonged culture interval.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19649647     DOI: 10.1007/s00418-009-0625-x

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  34 in total

1.  Transcriptional activity of the mouse oocyte genome: companion granulosa cells modulate transcription and chromatin remodeling.

Authors:  R De La Fuente; J J Eppig
Journal:  Dev Biol       Date:  2001-01-01       Impact factor: 3.582

Review 2.  Subnuclear organelles: new insights into form and function.

Authors:  Korie E Handwerger; Joseph G Gall
Journal:  Trends Cell Biol       Date:  2005-12-01       Impact factor: 20.808

Review 3.  Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation.

Authors:  Lisa M Mehlmann
Journal:  Reproduction       Date:  2005-12       Impact factor: 3.906

4.  Relationship between growth and meiotic maturation of the mouse oocyte.

Authors:  R A Sorensen; P M Wassarman
Journal:  Dev Biol       Date:  1976-06       Impact factor: 3.582

5.  Changes in global histone acetylation pattern in somatic cell nuclei after their transfer into oocytes at different stages of maturation.

Authors:  Helena Fulka
Journal:  Mol Reprod Dev       Date:  2008-03       Impact factor: 2.609

6.  Nuclei of adult mammalian somatic cells are directly reprogrammed to oct-4 stem cell gene expression by amphibian oocytes.

Authors:  James A Byrne; Stina Simonsson; Patrick S Western; John B Gurdon
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

7.  The distribution of RNA polymerase II largest subunit (RPB1) in the Xenopus germinal vesicle.

Authors:  Olivia Doyle; Jeffry L Corden; Christine Murphy; Joseph G Gall
Journal:  J Struct Biol       Date:  2002 Oct-Dec       Impact factor: 2.867

8.  Presence of permanently activated signal transducers and activators of transcription in nuclear interchromatin granules of unstimulated mouse oocytes and preimplantation embryos.

Authors:  Sandrine Truchet; Martine Chebrout; Chakib Djediat; Juana Wietzerbin; Pascale Debey
Journal:  Biol Reprod       Date:  2004-06-09       Impact factor: 4.285

9.  Accumulation and dynamics of proteins of the MCM family during mouse oogenesis and the first embryonic cell cycle.

Authors:  Lukasz Swiech; Katarzyna Kisiel; Renata Czolowska; Maciej Zientarski; Ewa Borsuk
Journal:  Int J Dev Biol       Date:  2007       Impact factor: 2.203

10.  Meiotic competence in vitro of pig oocytes isolated from early antral follicles.

Authors:  J Motlik; N Crozet; J Fulka
Journal:  J Reprod Fertil       Date:  1984-11
View more
  5 in total

Review 1.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

2.  Method to isolate polyribosomal mRNA from scarce samples such as mammalian oocytes and early embryos.

Authors:  Sara Scantland; Jean-Philippe Grenon; Marie-Hélène Desrochers; Marc-André Sirard; Edward W Khandjian; Claude Robert
Journal:  BMC Dev Biol       Date:  2011-02-15       Impact factor: 1.978

3.  Nucleus reprogramming/remodeling through selective enucleation (SE) of immature oocytes and zygotes: a nucleolus point of view.

Authors:  Helena Fulka; Pasqualino Loi; Luca Palazzese; Michal Benc; Josef Fulka Jr
Journal:  J Reprod Dev       Date:  2022-04-17       Impact factor: 2.215

4.  Dissecting the role of the germinal vesicle nuclear envelope and soluble content in the process of somatic cell remodelling and reprogramming.

Authors:  Helena Fulka; Atsuo Ogura; Pasqualino Loi; Josef Fulka Jr
Journal:  J Reprod Dev       Date:  2019-08-18       Impact factor: 2.214

5.  Evaluating the efficacy of the anticancer drug cetuximab by atomic force microscopy.

Authors:  Qingrong Zhang; Yan Shi; Haijiao Xu; Lulu Zhou; Jing Gao; Junguang Jiang; Mingjun Cai; Yuping Shan
Journal:  RSC Adv       Date:  2018-06-13       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.